封面
市场调查报告书
商品编码
1437827

全球维生素 B12 补充剂市场 - 全球行业分析、规模、份额、成长、趋势、预测 (2031) - 按形式、按最终用途行业、按地区

Vitamin B12 Supplement Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

出版日期: | 出版商: Fairfield Market Research | 英文 250 Pages | 商品交期: 2-5个工作天内

价格
简介目录

2024年至2031年,全球维生素B12补充剂市场规模预计将以8.0%的复合年增长率扩大,到2031年底将达到5亿美元。

全球维生素 B12 补充剂市场正在见证显着增长,这主要是由于人们对保持健康生活方式的重要性的认识不断提高。 维生素缺乏症的增加和素食主义的盛行等因素,特别是在发展中国家,极大地促进了补充剂需求的激增。 最近的研究强调了对维生素 B12 替代来源的需求,因为素食和纯素食饮食在世界各地变得越来越普遍,分别占人口的 11% 和 3%。 此外,正如世界卫生组织 (WHO) 所强调的那样,发展中国家普遍存在的与营养不良相关的健康问题进一步强调了补充维生素 B12 的必要性。

北美已成为维生素 B12 补充剂的重要市场,其中只有美国显着增长,预计到 2031 年市场价值将达到 1.6 亿美元。 素食和素食饮食的兴起,加上大量人口患有消化系统疾病,支撑了该地区对补充剂的强劲需求。 加拿大也提供了利润丰厚的商机,因为其大量人口选择无肉饮食并经历消化健康问题。

在美国,由于越来越多的人采用纯素食和素食生活方式,预计到 2031 年,维生素 B12 补充剂市场将达到 2530 万美元。 大约3%的人口是素食主义者,7%的人口是素食主义者。

在健康和营养意识不断提高的推动下,透过强化食品提供的维生素 B12 补充剂市场预计将出现强劲增长。 食品强化是解决营养缺乏问题的一种经济高效的解决方案,製造商正在投资研发以满足消费者对强化产品的需求。

本报告考察了全球维生素 B12 补充剂市场,并提供了市场概述,包括按格式、最终用途行业、地区划分的趋势以及进入市场的公司的竞争趋势。

目录

第 1 章执行摘要

第二章市场概述

  • 市场定义与细分
  • 市场动态
  • 价值链分析
  • 波特五力分析
  • 新冠肺炎 (COVID-19) 影响分析
  • 乌克兰和俄罗斯之间衝突的影响
  • 经济概况
  • 杵分析

第 3 章 2018-2031 年全球维生素 B12 补充剂市场前景

  • 2018-2031 年全球维生素 B12 补充剂市场前景(按形式、价值(百万美元))
  • 全球维生素 B12 补充剂市场前景(以最终用途产业)、价值(百万美元),2018-2031 年
  • 2018-2031 年全球维生素 B12 补充剂市场前景(按地区、价值(百万美元))

第 4 章北美维生素 B12 补充剂市场前景,2018-2031

第 5 章欧洲维生素 B12 补充剂市场前景,2018-2031

第 6 章亚太地区维生素 B12 补充品市场展望,2018-2031 年

第 7 章拉丁美洲维生素 B12 补充剂市场展望,2018-2031 年

第 8 章:2018-2031 年中东及非洲维生素 B12 补充品市场前景

第九章竞争态势

  • 按製造商和最终用途行业划分的热图
  • 2023 年公司市占率分析
  • 竞争对手仪表板
  • 公司简介
    • Apotheca Inc.
    • Merck Group
    • Charkit Chemical Company LLC
    • Johnlee Pharmaceuticals Pvt. Ltd
    • American Regent, Inc.
    • Koninklijke DSM N.V
    • Bristol-Myers Squibb Company
    • Sanofi-Aventis
    • Pfizer Inc.
    • Chemkart India Pvt. Ltd

第 10 章附录

简介目录

Fairfield Market Research, a leading market intelligence firm, has released its latest comprehensive analysis report on the global Vitamin B12 Supplement market, providing valuable insights into the industry's current status and future trajectory. The report, based on meticulous research and robust data analysis, indicates significant growth prospects for the market, with sales expected to reach US$ 500 Million by the end of 2031, reflecting a projected Compound Annual Growth Rate (CAGR) of 8.0% from 2024 to 2031.

Growing Demand Fueled by Health Awareness and Dietary Trends

The global market for Vitamin B12 Supplements is witnessing notable growth, primarily driven by increasing public awareness of the importance of maintaining healthy lifestyles. Factors such as the rise in vitamin deficiencies, particularly in developing nations, and the growing adoption of veganism have significantly contributed to the surge in demand for these supplements. According to recent studies, the prevalence of vegetarian and vegan diets globally, accounting for 11% and 3% of the population, respectively, underscores the need for alternative sources of Vitamin B12. Additionally, malnutrition-related health issues prevalent in developing countries, as highlighted by the World Health Organization, further underscore the necessity for Vitamin B12 supplementation.

Regional Market Dynamics: Opportunities and Trends

North America: Leading the Charge in Vitamin B12 Supplementation

North America emerges as a prominent market for Vitamin B12 Supplements, with the United States alone projected to witness substantial growth, reaching a market value of US$ 160 Million by 2031. The increasing adoption of vegan and vegetarian diets, coupled with a significant population grappling with digestive disorders, underscores the region's robust demand for these supplements. Canada also presents lucrative opportunities, driven by a sizable population opting for meat-free diets and experiencing digestive health issues.

United Kingdom: Embracing Veganism and Vegetarianism

In the UK, the market for Vitamin B12 Supplements is expected to reach US$ 25.3 Million by 2031, driven by a rising number of individuals embracing vegan and vegetarian lifestyles. Approximately 3% of the population identifies as vegan, while 7% adhere to a vegetarian diet, indicating a growing market for B12 supplements.

India and Germany: Addressing Dietary Deficiencies

India and Germany represent significant markets for Vitamin B12 Supplements, fueled by a substantial portion of their populations adhering to vegetarian or vegan diets. In India, where 24% of the population is vegetarian and 9% vegan, the market is projected to expand steadily throughout the assessment period. Similarly, in Germany, where 3.2% of the population practices veganism, alongside rising concerns over digestive health and mental well-being, the market is poised for significant growth.

End-Use Industries and Product Forms Driving Growth

Fortified Food & Beverage: Meeting Nutritional Needs

The market for Vitamin B12 Supplements through Fortified Food & Beverage is expected to witness robust growth, driven by increasing awareness of health and nutrition. Food fortification presents a cost-effective solution to address nutrient deficiencies, with manufacturers investing in research and development to meet consumer demand for fortified products.

Powder Form: Versatile and Effective

The powder form of Vitamin B12 Supplements is anticipated to experience prominent growth, owing to its water-soluble nature and versatility in addressing various health concerns. With consumers seeking convenient and effective supplementation options, powdered supplements offer a convenient solution for incorporation into beverages, foods, and dietary products.

Competitive Analysis: Innovation and Investment

Leading players in the Vitamin B12 Supplement industry, including Chem Kart India Pvt Ltd, Pfizer Inc., Sanofi-Aventis, and others, are actively engaged in research and development initiatives to enhance product quality and meet evolving consumer preferences. Investment in advanced manufacturing facilities underscores the industry's commitment to addressing global demand for high-quality supplements.

Some key companies are:

  • Chem Kart India Pvt Ltd
  • Pfizer Inc.
  • Sanofi-Aventis
  • Bristol-Myers Squibb Company
  • Konikilijke DSM N.V.
  • Johnlee Pharmaceutical Pvt Ltd.
  • Charkit Chemical.
  • American Regent
  • Apotheca Inc.
  • Merck Group

Segmentation of the Global Vitamin B12 Supplement Market:

By Form

  • Tablet
  • Powder
  • Liquid
  • Capsule

By End Use Industry

  • Fortified Food & Beverages
  • Pharmaceutical
  • Health And Personal Care
  • Agriculture, Animal Feed, Poultry

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Vitamin B12 Supplement Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Vitamin B12 Supplement Market Outlook, 2018 - 2031

  • 3.1. Global Vitamin B12 Supplement Market Outlook, by Form, Value (US$ Mn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Tablet
      • 3.1.1.2. Powder
      • 3.1.1.3. Liquid
      • 3.1.1.4. Capsule
  • 3.2. Global Vitamin B12 Supplement Market Outlook, by End Use Industry, Value (US$ Mn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Fortified Food & Beverages
      • 3.2.1.2. Pharmaceutical
      • 3.2.1.3. Health And Personal Care
      • 3.2.1.4. Agriculture, Animal Feed, Poultry
  • 3.3. Global Vitamin B12 Supplement Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. North America
      • 3.3.1.2. Europe
      • 3.3.1.3. Asia Pacific
      • 3.3.1.4. Latin America
      • 3.3.1.5. Middle East & Africa

4. North America Vitamin B12 Supplement Market Outlook, 2018 - 2031

  • 4.1. North America Vitamin B12 Supplement Market Outlook, by Form, Value (US$ Mn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Tablet
      • 4.1.1.2. Powder
      • 4.1.1.3. Liquid
      • 4.1.1.4. Capsule
  • 4.2. North America Vitamin B12 Supplement Market Outlook, by End Use Industry, Value (US$ Mn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Fortified Food & Beverages
      • 4.2.1.2. Pharmaceutical
      • 4.2.1.3. Health And Personal Care
      • 4.2.1.4. Agriculture, Animal Feed, Poultry
    • 4.2.2. BPS Analysis/Market Attractiveness Analysis
  • 4.3. North America Vitamin B12 Supplement Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. U.S. Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 4.3.1.2. U.S. Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
      • 4.3.1.3. Canada Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 4.3.1.4. Canada Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Vitamin B12 Supplement Market Outlook, 2018 - 2031

  • 5.1. Europe Vitamin B12 Supplement Market Outlook, by Form, Value (US$ Mn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Tablet
      • 5.1.1.2. Powder
      • 5.1.1.3. Liquid
      • 5.1.1.4. Capsule
  • 5.2. Europe Vitamin B12 Supplement Market Outlook, by End Use Industry, Value (US$ Mn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Fortified Food & Beverages
      • 5.2.1.2. Pharmaceutical
      • 5.2.1.3. Health And Personal Care
      • 5.2.1.4. Agriculture, Animal Feed, Poultry
    • 5.2.2. BPS Analysis/Market Attractiveness Analysis
  • 5.3. Europe Vitamin B12 Supplement Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Germany Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 5.3.1.2. Germany Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
      • 5.3.1.3. U.K. Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 5.3.1.4. U.K. Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
      • 5.3.1.5. France Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 5.3.1.6. France Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
      • 5.3.1.7. Italy Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 5.3.1.8. Italy Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
      • 5.3.1.9. Turkey Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 5.3.1.10. Turkey Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
      • 5.3.1.11. Russia Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 5.3.1.12. Russia Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
      • 5.3.1.13. Rest of Europe Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 5.3.1.14. Rest of Europe Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Vitamin B12 Supplement Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Vitamin B12 Supplement Market Outlook, by Form, Value (US$ Mn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Tablet
      • 6.1.1.2. Powder
      • 6.1.1.3. Liquid
      • 6.1.1.4. Capsule
  • 6.2. Asia Pacific Vitamin B12 Supplement Market Outlook, by End Use Industry, Value (US$ Mn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Fortified Food & Beverages
      • 6.2.1.2. Pharmaceutical
      • 6.2.1.3. Health And Personal Care
      • 6.2.1.4. Agriculture, Animal Feed, Poultry
    • 6.2.2. BPS Analysis/Market Attractiveness Analysis
  • 6.3. Asia Pacific Vitamin B12 Supplement Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. China Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 6.3.1.2. China Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
      • 6.3.1.3. Japan Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 6.3.1.4. Japan Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
      • 6.3.1.5. South Korea Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 6.3.1.6. South Korea Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
      • 6.3.1.7. India Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 6.3.1.8. India Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
      • 6.3.1.9. Southeast Asia Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 6.3.1.10. Southeast Asia Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
      • 6.3.1.11. Rest of Asia Pacific Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 6.3.1.12. Rest of Asia Pacific Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Vitamin B12 Supplement Market Outlook, 2018 - 2031

  • 7.1. Latin America Vitamin B12 Supplement Market Outlook, by Form, Value (US$ Mn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Tablet
      • 7.1.1.2. Powder
      • 7.1.1.3. Liquid
      • 7.1.1.4. Capsule
  • 7.2. Latin America Vitamin B12 Supplement Market Outlook, by End Use Industry, Value (US$ Mn), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Fortified Food & Beverages
      • 7.2.1.2. Pharmaceutical
      • 7.2.1.3. Health And Personal Care
      • 7.2.1.4. Agriculture, Animal Feed, Poultry
    • 7.2.2. BPS Analysis/Market Attractiveness Analysis
  • 7.3. Latin America Vitamin B12 Supplement Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Brazil Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 7.3.1.2. Brazil Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
      • 7.3.1.3. Mexico Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 7.3.1.4. Mexico Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
      • 7.3.1.5. Argentina Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 7.3.1.6. Argentina Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
      • 7.3.1.7. Rest of Latin America Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 7.3.1.8. Rest of Latin America Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Vitamin B12 Supplement Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Vitamin B12 Supplement Market Outlook, by Form, Value (US$ Mn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Tablet
      • 8.1.1.2. Powder
      • 8.1.1.3. Liquid
      • 8.1.1.4. Capsule
  • 8.2. Middle East & Africa Vitamin B12 Supplement Market Outlook, by End Use Industry, Value (US$ Mn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Fortified Food & Beverages
      • 8.2.1.2. Pharmaceutical
      • 8.2.1.3. Health And Personal Care
      • 8.2.1.4. Agriculture, Animal Feed, Poultry
  • 8.3. Middle East & Africa Vitamin B12 Supplement Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. GCC Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 8.3.1.2. GCC Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
      • 8.3.1.3. South Africa Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 8.3.1.4. South Africa Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
      • 8.3.1.5. Egypt Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 8.3.1.6. Egypt Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
      • 8.3.1.7. Nigeria Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 8.3.1.8. Nigeria Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
      • 8.3.1.9. Rest of Middle East & Africa Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 8.3.1.10. Rest of Middle East & Africa Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Manufacturer vs by End Use Industry Heatmap
  • 9.2. Company Market Share Analysis, 2023
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Apotheca Inc.
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. Merck Group
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. Charkit Chemical Company LLC
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Johnlee Pharmaceuticals Pvt. Ltd
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. American Regent, Inc.
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. Koninklijke DSM N.V
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. Bristol-Myers Squibb Company
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Sanofi-Aventis
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development
    • 9.4.9. Pfizer Inc.
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Product Portfolio
      • 9.4.9.3. Financial Overview
      • 9.4.9.4. Business Strategies and Development
    • 9.4.10. Chemkart India Pvt. Ltd
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Product Portfolio
      • 9.4.10.3. Financial Overview
      • 9.4.10.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations